Imaging-genomics reveals driving pathways of MRI derived volumetric tumor phenotype features in Glioblastoma.

GBM volumetric features extracted from MRI are significantly enriched for information about the biological state of a tumor that impacts patient outcomes. Clinical decision-support systems could exploit this information to develop personalized treatment strategies on the basis of noninvasive imaging.